Actavis Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS LABS, and what generic and branded alternatives to ACTAVIS LABS drugs are available?
ACTAVIS LABS has one hundred and one approved drugs.
There are thirteen tentative approvals on ACTAVIS LABS drugs.
Drugs and US Patents for Actavis Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Labs Fl Inc | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET, EXTENDED RELEASE;ORAL | 090153-002 | Mar 25, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl Inc | FENTANYL CITRATE | fentanyl citrate | TABLET;SUBLINGUAL | 207338-001 | Nov 17, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl | ISOTRETINOIN | isotretinoin | CAPSULE;ORAL | 205063-006 | Mar 31, 2021 | AB2 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | CABERGOLINE | cabergoline | TABLET;ORAL | 078035-001 | Apr 21, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Labs Fl Inc | VALGANCICLOVIR HYDROCHLORIDE | valganciclovir hydrochloride | FOR SOLUTION;ORAL | 205220-001 | Jul 18, 2016 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Actavis Labs Fl Inc | NAPROXEN SODIUM | naproxen sodium | TABLET, EXTENDED RELEASE;ORAL | 075416-001 | Aug 27, 2002 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Actavis Labs
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Actavis Labs Ut Inc | LOXITANE IM | loxapine hydrochloride | INJECTABLE;INJECTION | 018039-001 | Approved Prior to Jan 1, 1982 | 3,546,226 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Here is a list of applicants with similar names.